Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings

Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance

(2018) Robert A. Kyle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018

(2018) Morie A. Gertz   Blood Cancer Journal

Therapies for cardiac light chain amyloidosis: An update

(2018) Alberto Aimo et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

(2018) Mathew S. Maurer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Value of cardiac biomarker measurement in the differential diagnosis of infiltrative cardiomyopathy patients with preserved left ventricular systolic function

(2018) Kai Hu et al.   Journal of Thoracic Disease

Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers

(2018) Panagiota Kyriakou et al.   BMC Cardiovascular Disorders

Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths

(2017) Esther González-López et al.   EUROPEAN HEART JOURNAL

Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis

(2017) Francesco Cappelli et al.   JOURNAL OF NUCLEAR CARDIOLOGY

PET-CT evaluation of amyloid systemic involvement with [18F]-florbetaben in patient with proved cardiac amyloidosis: a case report

(2017) Dario Genovesi et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Magnetic Resonance in Transthyretin Cardiac Amyloidosis

(2017) Ana Martinez-Naharro et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

“Popeye” Sign

(2017) Naoki Yoshida et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis – Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)

(2017) Arnt V. Kristen et al.   PLoS One

Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis

(2016) Lei Zhao et al.   BMC Cardiovascular Disorders

Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisCLINICAL PERSPECTIVE

(2016) Julian D. Gillmore et al.   CIRCULATION

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN HEART JOURNAL

The Relation of Ejection Fraction and Global Longitudinal Strain in Amyloidosis: Implications for Differential Diagnosis

(2016) Efstathios D. Pagourelias et al.   JACC-Cardiovascular Imaging

Echocardiographic and Biohumoral Characteristics in Patients With AL and TTR Amyloidosis at Diagnosis

(2015) Francesco Cappelli et al.   CLINICAL CARDIOLOGY

Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction

(2015) Esther González-López et al.   EUROPEAN HEART JOURNAL

Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness

(2015) Thibaud Damy et al.   EUROPEAN HEART JOURNAL

Differential Myocyte Responses in Patients with Cardiac Transthyretin Amyloidosis and Light-Chain Amyloidosis: A Cardiac MR Imaging Study

(2015) Marianna Fontana et al.   RADIOLOGY

T1 mapping and survival in systemic light-chain amyloidosis

(2014) S. M. Banypersad et al.   EUROPEAN HEART JOURNAL

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

(2014)   EUROPEAN HEART JOURNAL

High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis

(2014) A Dispenzieri et al.   HEART

Cardiovascular magnetic resonance for amyloidosis

(2014) Marianna Fontana et al.   HEART FAILURE REVIEWS

CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis

(2014) Jason N. Dungu et al.   JACC-Cardiovascular Imaging

Comparison Between99mTc-Diphosphonate Imaging and MRI With Late Gadolinium Enhancement in Evaluating Cardiac Involvement in Patients With Transthyretin Familial Amyloid Polyneuropathy

(2013) Fabio Minutoli et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Prevalence and Prognostic Value of Conduction Disturbances at the Time of Diagnosis of Cardiac AL Amyloidosis

(2013) Michele Boldrini et al.   ANNALS OF NONINVASIVE ELECTROCARDIOLOGY

Diagnostic and Prognostic Value of Low QRS Voltages in Cardiac AL Amyloidosis

(2013) Roberta Mussinelli et al.   ANNALS OF NONINVASIVE ELECTROCARDIOLOGY

Systemic light chain amyloidosis: an update for treating physicians

(2013) G. Merlini et al.   BLOOD

99m Tc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses

(2013) Sabahat Bokhari et al.   Circulation-Cardiovascular Imaging

Nuclear imaging modalities for cardiac amyloidosis

(2013) Sabahat Bokhari et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure

(2012) Giovanni Palladini et al.   AMERICAN JOURNAL OF HEMATOLOGY

Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective

(2012) C. Rapezzi et al.   EUROPEAN HEART JOURNAL

Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis

(2012) Dermot Phelan et al.   HEART

Prognostic value of fragmented QRS in cardiac AL amyloidosis

(2012) Stefano Perlini et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

AL Amyloidosis

(2012) Estelle Desport et al.   Orphanet Journal of Rare Diseases

Quantification of Extracellular Matrix Expansion by CMR in Infiltrative Heart Disease

(2012) François-Pierre Mongeon et al.   JACC-Cardiovascular Imaging

Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of cardiac amyloidosis

(2011) A. D. Wechalekar et al.   HAEMATOLOGICA

High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly

(2011) Yoshiki Sekijima et al.   HUMAN PATHOLOGY

Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis

(2010) Stephanie Lehrke et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay

(2010) A. V. Kristen et al.   BLOOD

Comparison of Functional Status, Electrocardiographic, and Echocardiographic Parameters to Mortality in Endomyocardial-Biopsy Proven Cardiac Amyloidosis

(2009) Bethany A. Austin et al.   AMERICAN JOURNAL OF CARDIOLOGY

Systemic Cardiac Amyloidoses

(2009) Claudio Rapezzi et al.   CIRCULATION

Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine

(2009) G. Palladini et al.   CLINICAL CHEMISTRY

Differentiation of Hypertrophic Cardiomyopathy and Cardiac Amyloidosis from Other Causes of Ventricular Wall Thickening by Two-Dimensional Strain Imaging Echocardiography

(2008) Jing Ping Sun et al.   AMERICAN JOURNAL OF CARDIOLOGY

Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation inalpha2‐macroglobulinandtau: A population‐based autopsy study

(2008) Maarit Tanskanen et al.   ANNALS OF MEDICINE